References
- Thompson H I, Herbst E J, Meeker L K. Chemoprevention of mammary carcinogenesis: A comparative review of the efficacy of a polyamine antimetabolite, retinoids and selenium. J Natl Cancer Inst 1986; 77: 595–598
- Pierson H. New agents for preclinical study. Presented at the Chemoprevention Clinical Trials Workshop. May, 11–121987. DCPC, NCI, Bethesda, MD
- Ommen G. Cancer prevention in persons with asbestos related lung disease. Presented at the Chemoprevention Clinical Trials Workshop. May, 11–121987. DCPC, NCI, Bethesda, MD
- Spom M B, Newton D L. Chemoprevention of cancer with retinoids. Fed Proc 1979; 38: 2528–2534
- McCormick D L, Moon R C. Antipromotional activity of dietary N-(4-hydroxyphenyl)retinamide in two-stage skin tumorigenesis in CD-I and Senear mice. Cancer Lett 1986; 31: 133–138
- Moon R C, McCormick D L, Mehta R G. Inhibition of carcinogenesis by retinoids. Cancer Res 1983; 43: 2469s–2475s
- Peck G L. Chemoprevention of cancer with retinoids. Gynecol Oncol 1981; 12: S331–S340
- Moon R C, Thompson H I, Becci P J, et al. N-(4-hydroxyphenyl) retinamide, a new retinoid for prevention of breast cancer. Cancer Res 1979; 39: 1339–1346
- McCormick D L, Mehta R G, Thompson C A, et al. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyI)retinamide and ovariectomy. Cancer Res 1982; 42: 508–512
- Radcliffe J D, Moon R C. Effect of N-(4-hydroxyphenyl)retinamide on food intake, growth and mammary gland development in rats. Proc Soc Exp Biol Med 1983; 174: 270–275
- Paulson J D, Oldham J W, Preston R F, et al. Lack of genotoxicity of the cancer chemopreventive agent N-(4-hydroxyphenyl)retinamide. Fundam Appl Toxicol 1985; 5: 144–150
- Bunk M J, Telang N T, Higgins P J, et al. Effect of N-(4-hydroxyphenyl)retinamkie on murine mammary tumor cells in culture. Nutr Cancer 1985; 7: 105–130
- Formelli F, Carsana R, Costa A. N-(4-hydroxyphenyl)retinamide (4-HPR) lowers plasma retinol levels in rats. Med Sci Rev 1987; 15: 843–844
- Veronesi U, Costa A, Formelli F, et al. N-(4-hydroxyphenyl)retina-mide, a potential chemopreventive agent for breast cancer-one year phase I report. Istituto Nazionale Tumori, Milan. April, 1987
- Veronesi U, Costa A, De Palo G, et al. Prevention of contralateral breast cancer with fenretinide. Milan. March, 1987
- Baum M, Brinkley D M, Dossett J A, et al. Control trial of tamoxifen and adjuvant agent in management of early breast cancer. Lancet 1983; 1: 257–269
- Gazet J C. Breast cancer prevention: a hypothesis. Presented at the First International Symposium on the prevention of breast cancer. March, 201987. St. George's Hospital, London